Selective apoptosis of natural killer-cell tumours by L-asparaginase

British Journal of Haematology

Volumn 130, Issue 6, 2005, Pages 860-868

  Ando, Miki ^a   Sugimoto, Koichi ^a   Kitoh, Toshiyuki ^b   Sasaki, Makoto ^a   Mukai, Kouichi ^c   Ando, Jun ^a   Egashira, Motoki ^a   Schuster, Sheldon M ^d   Oshimi, Kazuo ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Shiga Medical Center   (Japan)

^c SHIGA MEDICAL CENTER FOR ADULTS   (Japan)

^d KECK GRADUATE INSTITUTE   (United States)

Author keywords

Apoptosis; Asparagine synthetase; Chronic NK lymphocytosis; L asparaginase; Natural killer cell tumour

Indexed keywords

ASPARAGINASE; CYTARABINE; CYTOSINE; DOXORUBICIN; MESSENGER RNA; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC AGENT; ASPARTATE AMMONIA LIGASE; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPHOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; LYMPHOCYTOSIS; NICK END LABELING; PATHOLOGY; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPARAGINASE; ASPARTATE-AMMONIA LIGASE; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; IN SITU NICK-END LABELING; KILLER CELLS, NATURAL; LEUKEMIA, T-CELL; LYMPHOCYTOSIS; LYMPHOMA, T-CELL; RNA, MESSENGER; RNA, NEOPLASM;

EID: 27244449294     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05694.x     Document Type: Article

References (35)

1. Aslanian A.M. Fletcher B.S. Kilberg M.S. ( 2001) Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. The Biochemical Journal, 357, 321 328.
2. Chan J.K.C. Sin V.C. Wong K.F. Ng C.S. Tsang W.Y.W. Chan C.H. Cheung M.M.C. Lau W.H. ( 1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood, 89, 4501 4513.
3. Chaperot L. Bendriss N. Manches O. Gressin R. Maynadie M. Trimoreau F. Orfeuvre H. Corront B. Feuillard J. Sotto J.J. Bensa J.C. Briere F. Plumas J. Jacob M.C. ( 2001) Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood, 97, 3210 3217.
4. Clarkson B. Krakoff I. Burchenal J. Karnofsky D. Golbey R. Dowling M. Oettgen H. Lipton A. ( 1970) Clinical results of treatment with E.coli l-asparaginase in adults with leukemia, lymphoma and solid tumors. Cancer, 25, 279 305.
5. Egashira M. Kawamata N. Sugimoto K. Kaneko T. Oshimi K. ( 1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporine A and its analogue, PSC833. Blood, 93, 599 606.
6. Ertel I.J. Nesbit M.E. Hammond D. Weiner J. Sather H. ( 1979) Effective dose of l-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from a children's cancer study group. Cancer Research, 39, 3893 3896.
7. + malignancies. Blood, 99, 1556 1563.
8. Fumarola C. Zerbini A. Guidotti G.G. ( 2001) Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis. Cell Death and Differentiation, 8, 1004 1013.
9. Gong J.H. Maki G. Klingemann H.G. ( 1994) Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia, 8, 652 658.
10. Hercend T. Schmidt R.E. ( 1988) Characteristics and uses of natural killer cells. Immunology Today, 9, 291 293.
11. Hutson R.G. Kitoh T. Moraga D.A. Cosic S. Schuster S.M. Kilberg M.S. ( 1997) Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. American Journal of Physiology. Cell Physiology, 272, 1691 1699.
12. Imamura N. Kusunoki Y. Kawa-Ha K. Yomura K. Hara J. Oda K. Abe K. Dohy H. Inada T. Kajihara H. Kuramoto A. ( 1990) Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature: possible existence of a new clinical entity originating from the third lineage of lymphoid cells. British Journal of Haematology, 75, 49 59.
13. Irino T. Kitoh T. Koami K. Kashima T. Mukai K. Takeuchi E. Hongo T. Nakahata T. Schuster S.M. Osaka M. ( 2004) Establishment of real-time PCR method for quantitative analysis of asparagine synthetase expression. The Journal of Molecular Diagnostics, 6, 217 224.
14. Jaffe E.S. Harris N.L. Stein H. Vardiman J.W. ( 2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon.
15. + NK lymphomas: clinicopathologic features and prognosis. British Journal of Haematology, 97, 821 829.
16. Matsumoto Y. Nomura K. Kanda Y. Fujita Y. Nakao M. Ueda K. Horiike S. Yokota S. Kusuzaki K. Kitoh T. Watanabe A. Taniwaki M. ( 2003) Successful treatment with Erwinial-sparaginase for recurrent natural killer/T cell lymphoma. Leukemia & Lymphoma, 44, 879 882.
17. Oshimi K. ( 2003) Leukemia and lymphoma of natural killer lineage cells. International Journal of Hematology, 78, 18 23.
18. Pastan I. Gottesman M.M. ( 1994) Multidrug resistance. Annual Review of Medicine, 42, 277 286.
19. Remarkers-van Woerden N.L. Pieters R. Loonen A.H. Hubeek I. Drunen E. Beverloo H.B. Slater R.M. Harbott J. Seyfarth J. van Wering E.R. Hahlen K. Schmiegelow K. Janka-Schaub G.E. Veerman A.J.P. ( 2000) TEL/AML1 gene fusion is related to in vitro drug sensitivity for l-asparaginase in childhood acute lymphoblastic leukemia. Blood, 96, 1094 1099.
20. Robertson M.J. Ritz J. ( 1990) Biology and clinical relevance of human natural killer cells. Blood, 76, 2421 2438.
21. Sheng S. Moraga D.A. Van Heeke G. Schuster S.M. ( 1992) High-level expression of human asparagine synthetase and production of monoclonal antibodies for enzyme purification. Protein Expression and Purification, 3, 337 346.
22. Siu L.L.P. Chan J.K.C. Kwong Y.L. ( 2002) Natural killer cell malignancies: clinicopathologic and molecular features. Histology and Histopathology, 17, 539 554.
23. + pediatric ALL. Blood, 101, 2743 2747.
24. Stams W.A.G. den Boer M.L. Holleman A. Appel I.M. Beverloo B. van Wering E.R. Janka-Schaub G.E. Evans W.E. Pieters R. ( 2005) Asparagine synthetase expression is linked with l-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. Blood, 105, 4223 4225.
25. Story M.D. Voehringer D.W. Stephens L.C. Meyn R.E. ( 1993) l-Asparaginase kills lymphoma cells by apoptosis. Cancer Chemotherapy and Pharmacology, 32, 129 133.
26. Sugimoto K. Yamada K. Egashira M. Yazaki Y. Hirai H. Kikuchi A. Oshimi K. ( 1998) Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells. Blood, 91, 1407 1417.
27. Sugimoto K. Tamayose K. Sasaki M. Hayashi K. Oshimi K. ( 2002) Low-dose doxorubicin-induced necrosis in Jurkat cells and its acceleration and conversion to apoptosis by antioxidants. British Journal of Haematology, 118, 229 238.
28. Tefferi A. Li C.Y. Witzig T.E. Dhodapkar M.V. Okuno S.H. Phyliky R.L. ( 1994) Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood, 84, 2721 2725.
29. Trinchieri G. ( 1989) Biology of natural killer cells. Advances in Immunology, 47, 187 376.
30. Tsuchiyama J. Yoshino T. Mori M. Kondoh E. Oka T. Akagi T. Hiraki A. Nakayama H. Shibuya A. Ma Y. Kawabata T. Okada S. Harada M. ( 1998) Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Blood, 92, 1374 1383.
31. Ueno T. Ohtawa K. Mitsui K. Kodera Y. Hiroto M. Matsushima A. Inada Y. Nishimura H. ( 1997) Cell cycle arrest and apoptosis of leukemia cells induced by l-asparaginase. Leukemia, 11, 1858 1861.
32. Wagner A. Hempel G. Gumbinger H.G. Jurgens H. Boos J. ( 1999) Pharmacokinetics of anticancer drugs in vitro. Advance in Experimental Medicine and Biology, 457, 397 407.
33. Yamaguchi M. Kita K. Miwa H. Nishii K. Oka K. Ohno T. Shirakawa S. Fukumoto M. ( 1995) Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer, 76, 2351 2356.
34. Yamamoto T. Iwasaki T. Watanabe N. Oshimi K. Naito M. Tsuruo T. Kobayashi Y. ( 1993) Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Blood, 81, 1342 1346.
35. Yong W. Zheng W. Zhang Y. Zhu J. Wei Y. Zhu D. Li J. ( 2003) l-Asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma. International Journal of Hematology, 78, 163 167.